Investors
Share price
{{priceData.date}} {{priceData.time}}
{{'2023-10-16T11:00:43Z' | dateFormatFilter}}
Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Biosciences
Read more
{{'2023-10-13T12:48:19Z' | dateFormatFilter}}
Novo Nordisk raises sales and operating profit outlook for 2023
Read more
{{'2023-10-10T20:37:32Z' | dateFormatFilter}}
Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on interim analysis
Read more
Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.